Mature hepatocyte growth factor/scatter factor on the surface of human granulocytes is released by a mechanism involving activated factor Xa

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 6945-6953

  Ohnishi, Tomokazu ^a   Kakimoto, Kyoko ^a   Bandow, Kenjiro ^a   Lowenstein, Charles J ^b   Daikuhara, Yasushi ^a   Matsuguchi, Tetsuya ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; BLOOD CLOTTING FACTOR 10A; IODINE 125; MESSENGER RNA; SCATTER FACTOR; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; TISSUE INJURY; TISSUE REPAIR;

EID: 33646876017     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.6945     Document Type: Article

References (64)

1. Rosen, E. M., S. K. Nigam, and I. D. Goldberg. 1994. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J. Cell Biol. 127: 1783-1787.
2. Michalopoulos, G. K., and M. C. DeFrances. 1997. Liver regeneration. Science 276: 60-66.
3. Trusolino, L., L. Pugliese, and P. M. Comoglio. 1998. Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J. 12: 1267-1280.
4. Tsubouchi, H. 1999. Hepatocyte growth factor for liver disease. Hepatology 30: 333-334.
5. Birchmeier, C., and H. Brohmann. 2000. Genes that control the development of migrating muscle precursor cells. Curr. Opin. Cell Biol. 12: 725-730.
6. Ohnishi, T., and Y. Daikuhara. 2003. Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues. Arch. Oral Biol. 48: 797-804.
7. Tamura, M., N. Arakaki, H. Tsubouchi, H. Takada, and Y. Daikuhara. 1993. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J. Biol. Chem. 268: 8140-8145.
8. Matsunaga, T., E. Gohda, T. Takebe, Y. L. Wu, M. Iwao, H. Kataoka, and I. Yamamoto. 1994. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway. Exp. Cell Res. 210: 326-335.
9. 2 predominantly induces production of hepatocyte growth factor/scatter factor in human dental pulp in acute inflammation. J. Dent. Res. 79: 748-755.
10. Grant, D. S., H. K. Kleinman, I. D. Goldberg, M. M. Bhargava, B. J. Nickoloff, J. L. Kinsella, P. Polverini, and E. M. Rosen. 1993. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 90: 1937-1941.
11. Taniyama, Y., R. Morishita, M. Aoki, H. Nakagami, K. Yamamoto, K. Yamazaki, K. Matsumoto, T. Nakamura, Y. Kaneda, and T. Ogihara. 2001. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 8: 181-189.
12. Tsubouchi, H., Y. Niitani, S. Hirono, H. Nakayama, E. Gohda, N. Arakaki, O. Sakiyama, K. Takahashi, M. Kimoto, S. Kawakami, et al. 1991. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13: 1-5.
13. Kawakami, S., H. Tsubouchi, S. Nakagawa, S. Hirono, N. Arakaki, O. Nakamura, Y. Daikuhara, and T. Arima. 1994. Expression of hepatocyte growth factor in normal and carbon tetrachloride-treated monkeys. Hepatology 20: 1255-1260.
14. Yanagita, K., K. Matsumoto, K. Sekiguchi, H. Ishibashi, Y. Niho, and T. Nakamura. 1993. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268: 21212-21217.
15. Ueda, T., Y. Takeyama, A. Toyokawa, S. Kishida, M. Yamamoto, and Y. Saitoh. 1996. Significant elevation of serum human hepatocyte growth factor levels in patients with acute pancreatitis. Pancreas 12: 76-83.
16. Seidel, C., M. Bourset, I. Turesson, N. Abildgaard, A. Sundan, and A. Waage. 1998. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma: the Nordic Myeloma Study Group. Blood 91: 806-812.
17. Beppu, K., A. Uchiyama, T. Morisaki, K. Nakamura, H. Noshiro, K. Matsumoto, T. Nakamura, M. Tanaka, and M. Katano. 2000. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. Anticancer Res. 20: 1263-1267.
18. Matsumori, A., Y. Furukawa, T. Hashimoto, K. Ono, T. Shioi, M. Okada, A. Iwasaki, R. Nishio, and S. Sasayama. 1996. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem. Biophys. Res. Commun. 221: 391-395.
19. Ono, K., A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama. 1997. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 95: 2552-2558.
20. Matsumori, A., S. Miyazaki, H. Takano, K. Ono, M. Okada, T. Miyamoto, H. Nonogi, S. Daikoku, K. Mitsudo, Y. Matsunaga, et al. 2000. Circulating hepatocyte growth factor as a marker of thrombus formation in unstable angina pectoris. Jpn. Circ. J. 64: 805-807.
21. Yoshitomi, Y., S. Kojima, T. Umemoto, K. Kubo, Y. Matsumoto, M. Yano, T. Sugi, and M, Kuramochi. 1999. Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease. J. Clin. Endocrinol. Metab. 84: 2425-2428.
22. Soeki, T., Y. Tamura, H. Shinohara, H. Tanaka, K. Bando, and N. Fukuda. 2000. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology 93: 168-174.
23. Grenier, A., S. Chollet-Martin, B. Crestani, C. Delarche, J. El Benna, A. Boutten, V. Andrieu, G. Durand, M. A. Gougerot-Pocidalo, M. Aubier, and M. Dehoux. 2002. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 99: 2997-3004.
24. Wislez, M., N. Rabbe, J. Marchal, B. Milleron, B. Crestani, C. Mayaud, M. Antoine, P. Soler, and J. Cadranel. 2003. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res. 63: 1405-1412.
25. Ohnishi, T., K. Kakimoto, S. Hashida, M. Fujii, S. Hirono, K. Nishiyama, Y. Amita, E. Ishikawa, H. Tsubouchi, and Y. Daikuhara. 2000. Development of highly sensitive enzyme-linked immunosorbent assays for hepatocyte growth factor/scatter factor (HGF/SF): determination of HGF/SF in serum and urine from normal human subjects. J. Immunol. Methods 244: 163-173.
26. Kajihara, T., T. Ohnishi, N. Arakaki, I. Semba, and Y. Daikuhara. 1999. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla. Arch. Oral Biol. 44: 135-147.
27. Arakaki, N., S. Kawakami, O. Nakamura, T. Ohnishi, H. Miyazaki, T. Ishii, H. Tsubouchi, and Y. Daikuhara. 1995. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 22: 1728-1734.
28. Sugawara, S., A. Sugiyama, E. Nemoto, H. Rikiishi, and H. Takada. 1998. Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect. Immun. 66: 3043-3049.
29. Kanof, M. E., and P. D. Smith. 1991. Immunologic studies in humans. In Current Protocols in Immunology. J. E. Coligan, A. D. Kruisbeek, D. H. Marguiles, E. M. Shevach, and W. Strober, eds. Wiley, New York, p. 7.0.1.
30. Harlan, J. M., P. D. Killen, F. M. Senecal, B. R. Schwartz, E. K. Yee, R. F. Taylor, P. G. Beatty, T. H. Price, and H. D. Ochs. 1985. The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood 66: 167-178.
31. Gohda, E., H. Tsubouchi, H. Nakayama, S. Hirono, O. Sakiyama, K. Takahashi, H. Miyazaki, S. Hashimoto, and Y. Daikuhara. 1988. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81: 414-419.
32. Misra, D. N., T. J. Gill III, and L. W. Estes. 1974. Lymphocyte plasma membranes. II. Cytochemical localization of 5′-nucleotidase in rat lymphocytes. Biochim. Biophys. Acta 352: 455-461.
33. Morre, D. J. 1974. Isolation of Golgi apparatus. Methods Enzymol. 31: 130-148.
34. Hunter, W. M., and F. C. Greenwood. 1962. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495-496.
35. Ohnishi, T., O. Nakamura, N. Arakaki, and Y. Daikuhara. 1997. Effect of phosphorylated rat fetuin on the growth of hepatocytes in primary culture in the presence of human hepatocyte-growth factor: evidence that phosphorylated fetuin is a natural modulator of hepatocyte-growth factor. Eur. J. Biochem. 243: 753-761.
36. Oishi, K., and K. Machida. 1997. Inhibition of neutrophil apoptosis by antioxidants in culture medium. Scand. J. Immunol. 45: 21-27.
37. Miyazawa, K., T. Shimomura, and N. Kitamura. 1996. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J. Biol. Chem. 271: 3615-3618.
38. Oh, I. S., S. S. So, K. Y. Jahng, and H. G. Kim. 2002. Hepatocyte growth factor upregulates thymosin β4 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 296: 401-405.
39. Takai, K., J. Hara, K. Matsumoto, G. Hosoi, Y. Osugi, A. Tawa, S. Okada, and T. Nakamura. 1997. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. Blood 89: 1560-1565.
40. Hara, T., A. Yokoyama, H. Ishihara, Y. Yokoyama, T. Nagahara, and M. Iwamoto. 1994. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Thromb. Haemost. 71: 314-319.
41. Broze, G. J., Jr. 1995. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu. Rev. Med. 46: 103-112.
42. Hetland, O., B. Johnsen, T. L. Janson, and H. Prydz. 1983. Intravenous injections of tissue thromboplastin and phospholipase C in rabbits. Scand. J. Clin. Lab Invest. 43: 35-40.
43. Bottaro, D. P., J. S. Rubin, D. L. Faletto, A. M. Chan, T. E. Kmiecik, G. F. Vande Woude, and S. A. Aaronson. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804.
44. Wang, P., and J. L. Zweier. 1996. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 271: 29223-29230.
45. Lentner, C. 1981. Geigy Scientific Tables. Ciba-Geigy Limited, Basel, Switzerland.
46. Toi, M., T. Taniguchi, T. Ueno, M. Asano, N. Funata, K. Sekiguchi, H. Iwanari, and T. Tominaga. 1998. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin. Cancer Res. 4: 659-664.
47. Aoyama, H., D. Naka, Y. Yoshiyama, T. Ishii, J. Kondo, M. Mitsuka, and T. Hayase. 1997. Isolation and conformational analysis of fragment peptide corresponding to the heparin-binding site of hepatocyte growth factor. Biochemistry 36: 10286-10291.
48. Huby, T., J. Chapman, and J. Thillet. 1997. Pathophysiological implication of the structural domains of lipoprotein(a). Atherosclerosis 133: 1-6.
49. Kim, T. H., E. Kim, D. Yoon, J. Kim, T. Y. Rhim, and S. S. Kim. 2002. Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases. Angiogenesis 5: 191-201.
50. Kim, J. S., J. H. Chang, H. K. Yu, J. H. Ahn, J. S. Yum, S. K. Lee, K. H. Jung, D. H. Park, Y. Yoon, S. M. Byun, and S. I. Chung. 2003. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). J. Biol. Chem. 278: 29000-29008.
51. Lamanuzzi, L. B., M. Mlairag, G. Pepe, and E. Anglés-Cano. 2004. Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a). Thromb. Haemost. 92: 1066-1075.
52. Chavakis, T., A. Athanasopoulos, J. S. Rhee, V. Orlova, T. Schmidt-Wöll, A. Bierhaus, A. E. May, I. Celik, P. P. Nawroth, and K. T. Preissner. 2005. Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood 105: 1036-1043.
53. Nishino, T., H. Hisha, N. Nishino, M. Adachi, and S. Ikehara. 1995. Hepatocyte growth factor as a hematopoietic regulator. Blood 85: 3093-3100.
54. Seiden, C., M. Jones, D. Wade, and H. Hodgson. 1990. Hepatotropin mRNA expression in human foetal liver development and in liver regeneration. FEBS Lett. 270: 81-84.
55. +). Exp. Hematol. 26: 885-894.
56. Börset, M., H. Hjorth-Hansen, C. Seidel, A. Sundan, and A. Waage. 1996. Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood 88: 3998-4004.
57. Nakamura, S., E. Gohda, Y. Matsuo, I. Yamamoto, and J. Minowada. 1994. Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients. Br. J. Haematol. 87: 640-642.
58. Matsumori, A., K. Ono, Y. Furukawa, M. Okada, and S. Sasayama. 1998. Circulating hepatocyte growth factor as an early marker of arterial thrombus formation. Jpn. Circ. J. 62: 311-313.
59. Ott, I. 2003. Tissue factor in acute coronary syndromes. Semin. Vasc. Med. 3: 185-192.
60. Taneda, H., K. Andoh, J. Nishioka, H. Takeya, and K. Suzuki. 1994. Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin. J. Biochem. 116: 589-597.
61. Pediaditakis, P., S. P. Monga, W. M. Mars, and G. K. Michalopoulos. 2002. Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa. J. Biol. Chem. 277: 14109-14115.
62. Nayeri, F., L. Brudin, I. Nilsson, and P. Forsberg. 2002. Sample handling and stability of hepatocyte growth factor in blood samples. Cytokine 19: 201-205.
63. Neurath, H., and K. A. Walsh. 1976. Role of proteolytic enzymes in biological regulation (a review). Proc. Natl. Acad. Sci. USA 73: 3825-3832.
64. Hertzberg, M. 1994. Biochemistry of factor X. Blood Rev. 8: 56-62.